Predictmedix Inc (CSE:PMED) (OTCQB:PDMEF) is collaborating with Tech Mahindra Ltd to offer artificial-intelligence-based healthcare solutions as a part of a suite of post-COVID-19 technologies.
Predictmedix said Tech Mahindra’s technologies focus on workplace health and safety, as underscored by the coronavirus (COVID-19) pandemic.
Since June, both companies have been working closely to incorporate Predictmedix's impairment detection technology along with its COVID-19 solutions into Tech Mahindra’s Health NxT platform.
WATCH: Predictmedix files two U.S. patents for technology while seeing big growth potential in Europe
“As part of Tech Mahindra Health NxT platform, we are leveraging the power of digital technologies including artificial intelligence and machine learning to augment our virtual health solutions, which will support health care providers and organizations to manage COVID-19 pandemic,” said Venugopal Reddy Kandimalla, senior vice president at Tech Mahindra, in a statement.
“While innovating in this space, we are also collaborating with partners with niche solutions to enhance our COVID suite of solutions for different markets on a regular basis."
Predictmedix said impairment caused by cannabis and alcohol is a major workplace health and safety issue.
As a result, the company has developed a proprietary technology that uses multispectral cameras and can be deployed in a workplace setting to screen for both cannabis and alcohol impairment along with screening for COVID-19 symptoms. Its technology uses facial and voice recognition to identify impairment.
Toronto-based Predictmedix said the technology is to be deployed using a software-as-a-service (SaaS) model on a revenue-sharing basis, which will involve an upfront customization fee followed by a monthly license fee based on the volume of screenings.
"The current COVID-19 pandemic has really brought upon an increased focus on workplace health and safety and our impairment detection along with COVID-19 symptom screening technologies fit in well with the suite of technologies being assembled by Tech Mahindra," said Dr Rahul Kushwah, chief operating officer of Predictmedix.
Contact the author: [email protected]
Follow him on Twitter @PatrickMGraham